( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

ISSN 2457-0400

Impact Factor  :  5.464

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR New Impact Factor

    Its our Pleasure to Inform you that WJAHR Impact Factor has been increased from  4.897 to 5.464 due to high quality Publication at International Level

  • .



    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR 1 January 2021 Issue has been Published, Kindly check it on


    JANUARY 2021 Issue has been successfully launched on 1 January 2021.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here




Jiyan Qasem*, Ibrahim Suliman and Firas Hussein


Background: Patients with sickle cell disease (SCD) are at increased risk of serious morbidity and mortality. Renal abnormalities in SCD are well known but renal involvement in Syrian patients with SCD has not been studied. Aim: We sought to identify the renal manifestations of sickle cell anemia among patients attending Tishreen University Hospital in Lattakia. Materials and Methods: This descriptive observational study included 76 patients (42 males, 34 females) diagnosed with sickle cell anemia confirmed by hemoglobin electrophoresis, and followed at Tishreen University Hospital in Lattakia, during the period between 2019 - 2020. The glomerular filtration rate was estimated (eGFR) using the ‘modification of diet in renal disease’ (MDRD) formula. All patients underwent evaluation by urine examination to detect hematuria, and 24- hour urine collection to measure to quantitate proteinuria. We constructed a multivariate logistic regression model to assess the association between hydroxyurea and proteinuria. Results: The renal manifestations of sickle cell anemia were as follows: glomerular hyperfiltration (9.2%), impaired renal function (31.6%), proteinuria (39.5%), and hematuria (19.7%). Patients with impaired renal function had a greater mean age and a higher prevalence of proteinuria compared with patients with normal renal function. A statistically significant inverse linear relationship was found between age and eGFR values (r = -0.547, p <0.001). The mean age of patients with proteinuria was greater compared to patients without proteinuria (P <0.05). Use of hydroxyurea is associated with a lower prevalence of proteinuria in patients with sickle cell anemia. The mean eGFR in patients treated with hydroxyurea was significantly greater compared to patients not treated with hydroxyurea (P <0.05). Conclusion: Renal abnormalities are present in a significant number of Syrian patients with SCD and proteinuria is the most common abnormality. Hydroxyurea use may prevent development of overt nephropathy or the progression of sickle cell disease nephropathy to end- stage renal disease.

[Full Text Article]